XTX Topco’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.01M Buy
+36,844
New +$8.58M 0.16% 82
2025
Q4
Sell
-60,929
Closed -$11.3M 3557
2025
Q3
$11.3M Buy
+60,929
New +$10.4M 0.59% 3
2025
Q2
Sell
-66,246
Closed -$11M 2774
2025
Q1
$11M Buy
66,246
+37,736
+132% +$5.9M 0.56% 6
2024
Q4
$4.12M Buy
28,510
+18,012
+172% +$2.79M 0.34% 19
2024
Q3
$1.7M Sell
10,498
-7,988
-43% -$1.27M 0.12% 194
2024
Q2
$2.7M Buy
+18,486
New +$2.75M 0.23% 63
2023
Q3
Sell
-2,517
Closed -$417K 1783
2023
Q2
$417K Buy
+2,517
New +$406K 0.07% 492
2022
Q3
Sell
-12,629
Closed -$2.24M 1245
2022
Q2
$2.24M Sell
12,629
-9,239
-42% -$1.65M 0.92% 3
2022
Q1
$3.88M Buy
21,868
+15,431
+240% +$2.63M 1.7% 1
2021
Q4
$1.1M Sell
6,437
-1,737
-21% -$284K 0.62% 8
2021
Q3
$1.32M Buy
+8,174
New +$1.39M 0.44% 31
2021
Q2
Sell
-6,247
Closed -$1.03M 954
2021
Q1
$1.03M Buy
+6,247
New +$1.01M 0.5% 8

Other funds holding JNJ

XTX Topco's JNJ Position: Q1 2026 in Review

XTX Topco opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 36,844 shares worth $9.01M. The stake represents 0.16% of the portfolio and ranks #82 among its holdings. This is a return to the name: XTX Topco previously reported a position in JNJ as recently as Q3 2025.

XTX Topco first reported a position in JNJ in Q1 2021 and has held it in 12 quarters since. The position peaked at $11.3M in Q3 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • XTX Topco held 36,844 shares of Johnson & Johnson worth $9.01M as of Q1 2026.
  • Johnson & Johnson was a new XTX Topco position in Q1 2026.
  • Johnson & Johnson made up 0.16% of XTX Topco's portfolio in Q1 2026, its #82 holding.
  • XTX Topco first reported a position in Johnson & Johnson in Q1 2021 and has held it in 12 quarters since.
  • XTX Topco's Johnson & Johnson position peaked at $11.3M in Q3 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.